9,024 research outputs found
Accurate,robust and harmonized implementation of morpho-functional imaging in treatment planning for personalized radiotherapy
In this work we present a methodology able to use harmonized PET/CT imaging in dose painting by number (DPBN) approach by means of a robust and accurate treatment planning system. Image processing and treatment planning were performed by using a Matlab-based platform, called CARMEN, in which a full Monte Carlo simulation is included. Linear programming formulation was developed for a voxel-by-voxel robust optimization and a specific direct aperture optimization was designed for an efficient adaptive radiotherapy implementation. DPBN approach with our methodology was tested to reduce the uncertainties associated with both, the absolute value and the relative value of the information in the functional image. For the same H&N case, a single robust treatment was planned for dose prescription maps corresponding to standardized uptake value distributions from two different image reconstruction protocols: One to fulfill EARL accreditation for harmonization of [18F]FDG PET/CT image, and the other one to use the highest available spatial resolution. Also, a robust treatment was planned to fulfill dose prescription maps corresponding to both approaches, the dose painting by contour based on volumes and our voxel-by-voxel DPBN. Adaptive planning was also carried out to check the suitability of our proposal.
Different plans showed robustness to cover a range of scenarios for implementation of harmonizing strategies by using the highest available resolution. Also, robustness associated to discretization level of dose prescription according to the use of contours or numbers was achieved. All plans showed excellent quality index histogram and quality factors below 2%. Efficient solution for adaptive radiotherapy based directly on changes in functional image was obtained. We proved that by using voxel-by-voxel DPBN approach it is possible to overcome typical drawbacks linked to PET/CT images, providing to the clinical specialist confidence enough for routinely implementation of functional imaging for personalized radiotherapy.Junta de Andalucía (FISEVI, reference project CTS 2482)European Regional Development Fund (FEDER
Three-Dimensional Dose Prediction for Lung IMRT Patients with Deep Neural Networks: Robust Learning from Heterogeneous Beam Configurations
The use of neural networks to directly predict three-dimensional dose
distributions for automatic planning is becoming popular. However, the existing
methods only use patient anatomy as input and assume consistent beam
configuration for all patients in the training database. The purpose of this
work is to develop a more general model that, in addition to patient anatomy,
also considers variable beam configurations, to achieve a more comprehensive
automatic planning with a potentially easier clinical implementation, without
the need of training specific models for different beam settings
Recommended from our members
Artificial Intelligence in Radiotherapy Treatment Planning: Present and Future.
Treatment planning is an essential step of the radiotherapy workflow. It has become more sophisticated over the past couple of decades with the help of computer science, enabling planners to design highly complex radiotherapy plans to minimize the normal tissue damage while persevering sufficient tumor control. As a result, treatment planning has become more labor intensive, requiring hours or even days of planner effort to optimize an individual patient case in a trial-and-error fashion. More recently, artificial intelligence has been utilized to automate and improve various aspects of medical science. For radiotherapy treatment planning, many algorithms have been developed to better support planners. These algorithms focus on automating the planning process and/or optimizing dosimetric trade-offs, and they have already made great impact on improving treatment planning efficiency and plan quality consistency. In this review, the smart planning tools in current clinical use are summarized in 3 main categories: automated rule implementation and reasoning, modeling of prior knowledge in clinical practice, and multicriteria optimization. Novel artificial intelligence-based treatment planning applications, such as deep learning-based algorithms and emerging research directions, are also reviewed. Finally, the challenges of artificial intelligence-based treatment planning are discussed for future works
Fraction-variant beam orientation optimization for non-coplanar IMRT
Conventional beam orientation optimization (BOO) algorithms for IMRT assume
that the same set of beam angles is used for all treatment fractions. In this
paper we present a BOO formulation based on group sparsity that simultaneously
optimizes non-coplanar beam angles for all fractions, yielding a
fraction-variant (FV) treatment plan. Beam angles are selected by solving a
multi-fraction FMO problem involving 500-700 candidate beams per fraction, with
an additional group sparsity term that encourages most candidate beams to be
inactive. The optimization problem is solved using the Fast Iterative
Shrinkage-Thresholding Algorithm. Our FV BOO algorithm is used to create
non-coplanar, five-fraction treatment plans for prostate and lung cases, as
well as a non-coplanar 30-fraction plan for a head and neck case. A homogeneous
PTV dose coverage is maintained in all fractions. The treatment plans are
compared with fraction-invariant plans that use a fixed set of beam angles for
all fractions. The FV plans reduced mean and max OAR dose on average by 3.3%
and 3.7% of the prescription dose, respectively. Notably, mean OAR dose was
reduced by 14.3% of prescription dose (rectum), 11.6% (penile bulb), 10.7%
(seminal vesicle), 5.5% (right femur), 3.5% (bladder), 4.0% (normal left lung),
15.5% (cochleas), and 5.2% (chiasm). Max OAR dose was reduced by 14.9% of
prescription dose (right femur), 8.2% (penile bulb), 12.7% (prox. bronchus),
4.1% (normal left lung), 15.2% (cochleas), 10.1% (orbits), 9.1% (chiasm), 8.7%
(brainstem), and 7.1% (parotids). Meanwhile, PTV homogeneity defined as D95/D5
improved from .95 to .98 (prostate case) and from .94 to .97 (lung case), and
remained constant for the head and neck case. Moreover, the FV plans are
dosimetrically similar to conventional plans that use twice as many beams per
fraction. Thus, FV BOO offers the potential to reduce delivery time for
non-coplanar IMRT
Beam mask and sliding window-facilitated deep learning-based accurate and efficient dose prediction for pencil beam scanning proton therapy
Purpose: To develop a DL-based PBSPT dose prediction workflow with high
accuracy and balanced complexity to support on-line adaptive proton therapy
clinical decision and subsequent replanning.
Methods: PBSPT plans of 103 prostate cancer patients and 83 lung cancer
patients previously treated at our institution were included in the study, each
with CTs, structure sets, and plan doses calculated by the in-house developed
Monte-Carlo dose engine. For the ablation study, we designed three experiments
corresponding to the following three methods: 1) Experiment 1, the conventional
region of interest (ROI) method. 2) Experiment 2, the beam mask (generated by
raytracing of proton beams) method to improve proton dose prediction. 3)
Experiment 3, the sliding window method for the model to focus on local details
to further improve proton dose prediction. A fully connected 3D-Unet was
adopted as the backbone. Dose volume histogram (DVH) indices, 3D Gamma passing
rates, and dice coefficients for the structures enclosed by the iso-dose lines
between the predicted and the ground truth doses were used as the evaluation
metrics. The calculation time for each proton dose prediction was recorded to
evaluate the method's efficiency.
Results: Compared to the conventional ROI method, the beam mask method
improved the agreement of DVH indices for both targets and OARs and the sliding
window method further improved the agreement of the DVH indices. For the 3D
Gamma passing rates in the target, OARs, and BODY (outside target and OARs),
the beam mask method can improve the passing rates in these regions and the
sliding window method further improved them. A similar trend was also observed
for the dice coefficients. In fact, this trend was especially remarkable for
relatively low prescription isodose lines. The dose predictions for all the
testing cases were completed within 0.25s
Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer: A Promising Approach.
Locally advanced pancreatic cancer (LAPC) is characterized by poor prognosis and low response durability with standard-of-care chemotherapy or chemoradiotherapy treatment. Stereotactic body radiation therapy (SBRT), which has a shorter treatment course than conventionally fractionated radiotherapy and allows for better integration with systemic therapy, may confer a survival benefit but is limited by gastrointestinal toxicity. Stereotactic MRI-guided adaptive radiation therapy (SMART) has recently gained attention for its potential to increase treatment precision and thus minimize this toxicity through continuous real-time soft-tissue imaging during radiotherapy. The case presented here illustrates the promising outcome of a 69-year-old male patient with LAPC treated with SMART with daily adaptive planning and respiratory-gated technique
Combined proton-photon therapy for non-small cell lung cancer
PURPOSE
Advanced non-small cell lung cancer (NSCLC) is still a challenging indication for conventional photon radiotherapy. Proton therapy has the potential to improve outcomes, but proton treatment slots remain a limited resource despite an increasing number of proton therapy facilities. This work investigates the potential benefits of optimally combined proton-photon therapy delivered using a fixed horizontal proton beam line in combination with a photon Linac, which could increase accessibility to proton therapy for such a patient cohort.
MATERIALS AND METHODS
A treatment planning study has been conducted on a patient cohort of seven advanced NSCLC patients. Each patient had a planning computed tomography scan (CT) and multiple repeated CTs from three different days and for different breath-holds on each day. Treatment plans for combined proton-photon therapy (CPPT) were calculated for individual patients by optimizing the combined cumulative dose on the initial planning CT only (non-adapted) as well as on each daily CT respectively (adapted). The impact of inter-fractional changes and/or breath-hold variability was then assessed on the repeat breath-hold CTs. Results were compared to plans for IMRT or IMPT alone, as well as against combined treatments assuming a proton gantry. Plan quality was assessed in terms of dosimetric, robustness and NTCP metrics.
RESULTS
Combined treatment plans improved plan quality compared to IMRT treatments, especially in regard to reductions of low and medium doses to organs at risk (OARs), which translated into lower NTCP estimates for three side effects. For most patients, combined treatments achieved results close to IMPT-only plans. Inter-fractional changes impact mainly the target coverage of combined and IMPT treatments, while OARs doses were less affected by these changes. With plan adaptation however, target coverage of combined treatments remained high even when taking variability between breath-holds into account.
CONCLUSIONS
Optimally combined proton-photon plans improve treatment plan quality compared to IMRT only, potentially reducing the risk of toxicity while also allowing to potentially increase accessibility to proton therapy for NSCLC patients
- …